ADPT
Adaptive Biotechnologies Corp
Key Financials
Operating Income
$-57123000
↑ 64.9%
Revenue
$277.0M
↑ 54.8%
Net Income
$-59499000
↑ 62.7%
EPS (Diluted)
$-0.39
↑ 63.9%
Cash & Equivalents
$70.5M
↑ 47.1%
Total Assets
$512.7M
↓ 4.9%
Total Liabilities
$287.7M
↓ 14.6%
Shareholders' Equity
$218.8M
↑ 7.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/16/2026 | View on SEC |
| 4 | 4/13/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| 4 | 4/10/2026 | View on SEC |
| 4 | 4/8/2026 | View on SEC |
| 4 | 4/8/2026 | View on SEC |
| 144 | 4/8/2026 | View on SEC |
| 144 | 4/8/2026 | View on SEC |
| 144 | 4/8/2026 | View on SEC |
| 144 | 4/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ADPT |
| Company Name | Adaptive Biotechnologies Corp |
| CIK | 1478320 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | WA |
| Phone | 206-659-0067 |